Key Takeaways
- Volume down, value up: FY23 volume fell ~10% YoY, but revenue grew ~10% YoY because the company shifted production quickly toward better-margin products when certain lines slowed.
- Greenfield plant is a FY25 story, not FY24: Management explicitly told investors to budget new-plant revenue only from FY25 onward; any FY24 output is a "bonus."
- Working capital stretched on inventory pile-up: Cash conversion was weak (INR35 crores of INR111 crores EBITDA) because Western customers postponed orders and Yasho had to honor raw-material purchase contracts.
- Margins held despite deflation: Selling prices dropped, but the company passed on cost declines at the same speed it had previously passed on cost increases, preserving overall profitability.
- What to watch next quarter: Whether the 1,500-ton debottlenecking fills as guided, any early customer-audit progress at Pakhajan, and whether inventory days start normalizing from the current stretched level.
Greenfield Project: Pakhajan Timeline & Economics
- Capex to date: INR180 crores incurred through March 2023 for the Pakhajan, Dahej site.
- Commercialization path: Sample submission, approval, and customer audits are targeted from November 2023 through March 2024 at the latest; real revenue begins in FY25.
- FY24 contribution: Management warned that any output from the new plant in FY24 should be treated as a bonus and not budgeted.
- Phase 1 ramp target: The company expects roughly 65% utilization of the new capacity in FY25 and hopes to achieve that level.
- Phase 2 decision gate: Any Phase 2 expansion decision will be taken only sometime in 2025, depending on how well Phase 1 capacities ramp.
- Infrastructure already sized ahead: Utility blocks and effluent treatment have been built to cover future needs for the next five years per environmental clearance requirements, so incremental capex intensity should be lower.
- Customer stickiness supports the ramp: Once approved as a source for a specialty-chemical chemistry, customers tend to stay unless the supplier makes a mistake; customers typically maintain only one or two approved sources, and Yasho can become a second, third, or fourth.
Parag Jhaveri: "I think we should budget only for next year, not this year. This year, what will happen will become bonus for us, not only for us, but for everybody. Real revenue starts from '24-'25."
FY24 Growth Bridge: Debottlenecking & Mix
- Capacity increase: The company has debottlenecked from 11,000 tons to 12,500 tons, and plants are now stabilizing to operate at the higher level.
- FY24 volume driver: Management expects minimum ~10% growth, driven by full utilization of the expanded 12,500-ton capacity and a market improvement.
- Incremental tons are industrial: The additional 1,500 tons will sit in the industrial segment, serving both export and domestic markets.
- Margin uplift from mix: Industrial chemicals carry higher gross margins than consumer chemicals, so the incremental industrial volume is expected to lift overall margins from the current 17.5%–18% range to 19.5%–20%.
- New products already contributing: Products A, B, C, and D are already being produced and sold at commercial scale; product B has meaningful current revenue, while A, C, and D started production or sales in the last year and are ramping.
Demand & Market Position
- FY23 volume dip explained: Full-year volume dropped ~10% YoY, with Q4 alone seeing a ~16–17% volume decline and a ~20% top-line drop YoY, driven by subdued demand and selling-price deflation.
- Mix agility protected value: Despite the volume decline, value grew ~10% YoY for the full year because the company shifted production quickly to different products when certain products slowed.
- Market-share defense: During the deflationary Q4, management chose to sell high-cost raw-material inventory at lower margins to keep plants running and avoid permanently losing market share.
- Demand tailwinds for new products: The lubricant market is growing 3%–5% globally due to environmental norms pushing cleaner fuels and more efficient lubricants; Make In India is forcing local sourcing; and post-disruption supply-chain diversification is creating openings.
- Market-share source unclear: When asked from whom Yasho is taking share, management declined to specify, offering only that the company is consolidating its position and winning customer trust.
Parag Jhaveri: "...we took us a side that lets sell the product with lesser margin, run the plant, whatever maximum capacity we can run it. So in order, we don't lose all. Once you lose the market, you lose forever."
Margins & Profitability
- Gross margin held flat YoY in Q4: Despite a better product mix, Q4 FY23 gross margin percentage was roughly similar to Q4 FY22 because high-cost raw-material inventory had to be sold at market prices during a period of deflation.
- Other expenses normalized: Q4 other expenses fell majorly due to normalization of export freight costs, which were elevated in the prior year, plus some benefit from product mix.
- Deflation pass-through worked: In a deflationary environment where selling prices dropped, the company maintained overall margins and profitability because it was able to pass on price drops at the same speed it had previously passed on cost increases.
- FY24 margin target: Margins are expected to improve from 17.5%–18% to 19.5%–20%, driven by the industrial segment's better margins.
Parag Jhaveri: "And when you have a price drop or when you have a deflection, not inflationary pressure, so your cost of the selling price goes down, but your incoming volume was intact, but still despite all this happened, we could maintain our overall margin on our profitability."
Working Capital & Balance Sheet
- Cash conversion suffered: Cash flow from operations was only INR35 crores out of INR111 crores of EBITDA, because the company is holding high inventory.
- Inventory pile-up cause: Customers in the Western world postponed or canceled orders for specialty chemicals, while Yasho had to honor raw-material purchase contracts.
- Normalization target: Management expects working capital to return to the comfort zone of 110–120 days.
- Future stretch expected: Some working-capital stretching is anticipated in FY25–26 after Pakhajan kicks in, because dealing with larger customers means they dictate payment terms; this is part of the rationale for guiding higher margins.
Parag Jhaveri: "When we work with smaller customers, we can dictate. When we are working with a larger organization, they dictate the terms. We don't."
New Product Pipeline & Long-Term Optionality
- Large demand pools identified: A couple of products in the pipeline have the potential for more than 100,000 to 200,000 metric tons of requirement; Yasho is starting with small capacity to test and will expand further after getting approvals.
- Tall targets, acknowledged gaps: Management described the revenue targets for the four new products on Slide 16 as tall, and acknowledged the company does not yet have full capability and capacity to capture the projected revenue.
- Export/domestic blend: The new products are expected to have a 30/70 or 60/40 export/domestic mix.
- Consolidated view only: Management evaluates Yasho overall, not unit-wise; Pakhajan margins will be part of consolidated results and not reported separately.
Parag Jhaveri: "...once you are in unless and until you make a mistake, you are there forever for this chemistry."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY24 revenue growth | Minimum ~10% growth, driven by full utilization of 12,500-ton capacity and market improvement | FY24 |
| FY24 margin improvement | Margins to improve from 17.5%–18% to 19.5%–20%, driven by industrial-segment mix | FY24 |
| Pakhajan commercialization | Sample submission, approval, and customer audits to complete; real revenue begins | Nov '23 to Mar '24; revenue from FY25 |
| Pakhajan Phase 1 utilization | ~65% utilization of new capacity expected | FY25 |
| Phase 2 expansion decision | Decision taken based on Phase 1 ramp performance | Sometime in 2025 |
| Working capital normalization | Return to comfort zone of 110–120 days | No date given |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Revenue | ~20% decline YoY, driven by ~16–17% volume drop and selling price decline |
| Full-year revenue growth | ~10% growth in value terms for FY23 |
| Full-year volume growth | ~9.5% decline for FY23 |
| Gross margin | Maintained YoY despite deflation, stiff competition, and subdued demand; product mix helped offset high-cost raw material inventory |
| EBITDA margin | 17.5%–18% current level; expected to improve to 19.5%–20% with industrial segment mix shift |
| Other expenses (quarter) | ~₹20 cr, down from ₹33 cr in Q4 FY22, driven by freight cost normalization |
| Other expenses (full year) | ~₹113 cr, roughly 60% variable and 40% fixed |
| Cash flow from operations to EBITDA conversion | ₹35 cr of ₹111 cr EBITDA converted, impacted by high inventory levels |
| Working capital cycle | 110–120 days comfortable level; currently stretched due to high-cost inventory and customer order postponements |
| Total capex incurred (Pakhajan, Dahej) | ~₹180 cr up to March 2023, of which ~₹150 cr on plant and machinery |
| Total capex committed (Greenfield) | ₹250 cr for land, building, and infrastructure |
| Capacity addition (Pakhajan Phase 1) | ~17,000 MTPA, taking total capacity to ~29,000–30,000 MTPA |
| FY24 revenue growth guidance | Minimum ~10%, driven by capacity increase from 11,000 to 12,500 tons and full utilization |
| Addressable market (lubricant) | ₹1,000–1,200 cr |
| Addressable market (rubber) | ₹500–600 cr |
| Addressable market (specialty) | ~₹50 cr |